PHP
TPTX

Parkman Healthcare Partners’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Parkman Healthcare Partners’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,962
Closed -$1.32M – 98
2021
Q1 		$1.32M Sell
13,962
-45,415
-76% -$5.4M 0.31% 68
2020
Q4 		$7.24M Sell
59,377
-50,958
-46% -$5.58M 1.85% 21
2020
Q3 		$9.64M Buy
110,335
+17
+0% +$1.18K 2.55% 9
2020
Q2 		$7.13M Buy
110,318
+30,000
+37% +$1.73M 2.01% 18
2020
Q1 		$3.59M Sell
80,318
-21,116
-21% -$1.12M 1.66% 22
2019
Q4 		$6.32M Buy
+101,434
New +$4.83M 1.82% 24

Other funds holding TPTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Parkman Healthcare Partners's TPTX Position: Q2 2021 in Review

Parkman Healthcare Partners sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2021, closing a stake of 13,962 shares — an estimated $1.32M sold.

Parkman Healthcare Partners first reported a position in TPTX in Q4 2019 and held it in 6 quarters. The position peaked at $9.64M in Q3 2020. 190 funds tracked by Wall St. Rank hold TPTX as of Q2 2021.

  • Parkman Healthcare Partners reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 13,962 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $1.32M.
  • Parkman Healthcare Partners first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Parkman Healthcare Partners's Turning Point Therapeutics, Inc. Common Stock position peaked at $9.64M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Parkman Healthcare Partners's 13F filing for Q2 2021, filed 13 Aug 2021.